Responses
Clinical and epidemiological research
Concise report
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
Compose a Response to This Article
Other responses
No responses have been published for this article.